- Pharmazeutisches Institut
- Faculty of Mathematics and Natural Sciences
- Drug design
- Enzyme inhibitors
- PROTACs
- Activity-based probes
C. Lemke, J. Benýšek, D. Brajtenbach, C. Breuer, A. Jílková, M. Horn, M. Buša, L. Ulrychová, A. Illies, K. F. Kubatzky, U. Bartz, M. Mareš, M. Gütschow (2021) An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity; J. Med. Chem. 64:13793-13806.
J. Breidenbach, C. Lemke, T. Pillaiyar, L. Schäkel,§ G. Al Hamwi, M. Diett, R. Gedschold, N. Geiger, V. Lopez, S. Mirza, V. Namasivayam, A. C. Schiedel, K. Sylvester, D. Thimm, C. Vielmuth, L. P. Vu, M. Zyulina, J. Bodem, M. Gütschow, C. E. Müller (2021) Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors; Angew. Chem. Int. Ed. 60:10423-10429.
C. Steinebach, Y. L. D. Ng, I. Sosič, C.-S. Lee, S. Chen, S. Lindner, L. P. Vu, A. Bricelj, R. Haschemi, M. Monschke, E. Steinwarz, K. G. Wagner, G. Bendas, J. Luo, M. Gütschow, J. Krönke (2020) Systematic Exploration of Different E3 Ubiquitin Ligases: An Approach Towards Potent and Selective CDK6 Degraders; Chem. Sci. 11:3474-3486.